DOPAMINERGIC LESIONS AND SUBJECTIVE EFFECTS OF METHYLPHENIDATE

多巴胺能损伤和哌醋甲酯的主观影响

• 批准号: 3853679
• 负责人: G R UHL
• 金额: --
• 依托单位: NATIONAL INSTITUTE ON DRUG ABUSE
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3853679
• 关键词: Parkinson's disease; antiparkinson drugs; dopamine; drug screening /evaluation; human subject; methylphenidate; psychopharmacology

The purpose of this research study is to examine whether the effect of the drug "Methylephenidate" that has been used in the therapy of Parkinson's disease is different in patients with Parkinson's disease compared with individuals without this disease. The study will test whether differences in feeling that these drugs can induce in normal individuals may or may not be present in patients with Parkinson's disease. Preliminary testing was initiated in 1989, the final phase of this study is now underway.

本研究的目的是检验 药物“Methylephenidate”已被用于治疗 帕金森病患者的病情不同 与没有这种疾病的人相比。 这项研究将测试 这些药物在正常人中引起的感觉差异是否 帕金森病患者中可能存在或不存在 疾病 初步测试于1989年开始， 这项研究现正进行中。